Core-binding factor and runx transcription factors promote adaptive natural killer cell responses

Science Immunology

Volumn 2, Issue 18, 2017, Pages

  Rapp, Moritz ^a   Lau, Colleen M ^a   Adams, Nicholas M ^a   Weizman, Orr El ^a   O’Sullivan, Timothy E ^a   Geary, Clair D ^a   Sun, Joseph C ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CBFB PROTEIN, MOUSE; CORE BINDING FACTOR BETA; RUNX1 PROTEIN, MOUSE; RUNX3 PROTEIN, MOUSE; STAT4 PROTEIN; STAT4 PROTEIN, MOUSE; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX3;

ANIMAL; C57BL MOUSE; DEFICIENCY; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MOUSE; NATURAL KILLER CELL;

ANIMALS; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CORE BINDING FACTOR ALPHA 3 SUBUNIT; CORE BINDING FACTOR BETA SUBUNIT; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; STAT4 TRANSCRIPTION FACTOR;

EID: 85044749133     PISSN: None     EISSN: 24709468     Source Type: Journal    
DOI: 10.1126/sciimmunol.aan3796     Document Type: Article

References (65)

1. A. Cerwenka, L. L. Lanier, Natural killer cell memory in infection, inflammation and cancer. Nat. Rev. Immunol. 16, 112–123 (2016).
2. T. E. O’Sullivan, J. C. Sun, L. L. Lanier, Natural killer cell memory. Immunity 43, 634–645 (2015).
3. + T cells. Nat. Rev. Immunol. 11, 645–657 (2011).
4. E. Vivier, D. H. Raulet, A. Moretta, M. A. Caligiuri, L. Zitvogel, L. L. Lanier, W. M. Yokoyama, S. Ugolini, Innate or adaptive immunity? The example of natural killer cells. Science 331, 44–49 (2011).
5. J. C. Sun, S. Lopez-Verges, C. C. Kim, J. L. DeRisi, L. L. Lanier, NK cells and immune “memory”. J. Immunol. 186, 1891–1897 (2011).
6. M. A. Cooper, J. M. Elliott, P. A. Keyel, L. Yang, J. A. Carrero, W. M. Yokoyama, Cytokine-induced memory-like natural killer cells. Proc. Natl. Acad. Sci. U.S.A. 106, 1915–1919 (2009).
7. S. Madera, M. Rapp, M. A. Firth, J. N. Beilke, L. L. Lanier, J. C. Sun, Type I IFN promotes NK cell expansion during viral infection by protecting NK cells against fratricide. J. Exp. Med. 213, 225–233 (2016).
8. S. Madera, J. C. Sun, Cutting edge: Stage-specific requirement of IL-18 for antiviral NK cell expansion. J. Immunol. 194, 1408–1412 (2015).
9. J. C. Sun, S. Madera, N. A. Bezman, J. N. Beilke, M. H. Kaplan, L. L. Lanier, Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J. Exp. Med. 209, 947–954 (2012).
10. A. M. Beaulieu, C. L. Zawislak, T. Nakayama, J. C. Sun, The transcription factor Zbtb32 controls the proliferative burst of virus-specific natural killer cells responding to infection. Nat. Immunol. 15, 546–553 (2014).
11. A. Morinobu, M. Gadina, W. Strober, R. Visconti, A. Fornace, C. Montagna, G. M. Feldman, R. Nishikomori, J. J. O’Shea, STAT4 serine phosphorylation is critical for IL-12-induced IFN- production but not for cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 99, 12281–12286 (2002).
12. G. Trinchieri, Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3, 133–146 (2003).
13. Y. Ito, Oncogenic potential of the RUNX gene family: ‘Overview’. Oncogene 23, 4198–4208 (2004).
14. A. Collins, D. R. Littman, I. Taniuchi, RUNX proteins in transcription factor networks that regulate T-cell lineage choice. Nat. Rev. Immunol. 9, 106–115 (2009).
15. I. Taniuchi, D. R. Littman, Epigenetic gene silencing by Runx proteins. Oncogene 23, 4341–4345 (2004).
16. Y. Zheng, S. Z. Josefowicz, A. Kas, T.-T. Chu, M. A. Gavin, A. Y. Rudensky, Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445, 936–940 (2007).
17. T. Egawa, R. E. Tillman, Y. Naoe, I. Taniuchi, D. R. Littman, The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells. J. Exp. Med. 204, 1945–1957 (2007).
18. + T cells. J. Immunol. 175, 1694–1705 (2005).
19. + regulatory T cells. Immunity 31, 609–620 (2009).
20. + T cells into the TH2 lineage by repressing GATA3 expression. J. Exp. Med. 198, 51–61 (2003).
21. D. Rudra, T. Egawa, M. M. W. Chong, P. Treuting, D. R. Littman, A. Y. Rudensky, Runx-CBF complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat. Immunol. 10, 1170–1177 (2009).
22. I. Taniuchi, M. Osato, T. Egawa, M. J. Sunshine, S.-C. Bae, T. Komori, Y. Ito, D. R. Littman, Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111, 621–633 (2002).
23. G. Vahedi, H. Takahashi, S. Nakayamada, H.-W. Sun, V. Sartorelli, Y. Kanno, J. J. O’Shea, STATs shape the active enhancer landscape of T cell populations. Cell 151, 981–993 (2012).
24. X. D. Zhao, X. Han, J. L. Chew, J. Liu, K. P. Chiu, A. Choo, Y. L. Orlov, W.-K. Sung, A. Shahab, V. A. Kuznetsov, G. Bourque, S. Oh, Y. Ruan, H.-H. Ng, C.-L. Wei, Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell 1, 286–298 (2007).
25. T. Ebihara, C. Song, S. H. Ryu, B. Plougastel-Douglas, L. Yang, D. Levanon, Y. Groner, M. D. Bern, T. S. Stappenbeck, M. Colonna, T. Egawa, W. M. Yokoyama, Runx3 specifies lineage commitment of innate lymphoid cells. Nat. Immunol. 16, 1124–1133 (2015).
26. D. E. Levy, J. E. Darnell Jr., Stats: Transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3, 651–662 (2002).
27. F. A. Letimier, N. Passini, S. Gasparian, E. Bianchi, L. Rogge, Chromatin remodeling by the SWI/SNF-like BAF complex and STAT4 activation synergistically induce IL-12R2 expression during human Th1 cell differentiation. EMBO J. 26, 1292–1302 (2007).
28. A. O’Sullivan, H.-C. Chang, Q. Yu, M. H. Kaplan, STAT4 is required for interleukin-12induced chromatin remodeling of the CD25 locus. J. Biol. Chem. 279, 7339–7345 (2004).
29. K. B. Nguyen, W. T. Watford, R. Salomon, S. R. Hofmann, G. C. Pien, A. Morinobu, M. Gadina, J. J. O’Shea, C. A. Biron, Critical role for STAT4 activation by type 1 interferons in the interferon- response to viral infection. Science 297, 2063–2066 (2002).
30. B. E. Bernstein, A. Meissner, E. S. Lander, The mammalian epigenome. Cell 128, 669–681 (2007).
31. G. R. Lee, S. T. Kim, C. G. Spilianakis, P. E. Fields, R. A. Flavell, T helper cell differentiation: Regulation by cis elements and epigenetics. Immunity 24, 369–379 (2006).
32. C. B. Wilson, E. Rowell, M. Sekimata, Epigenetic control of T-helper-cell differentiation. Nat. Rev. Immunol. 9, 91–105 (2009).
33. F. Zhang, M. Boothby, T helper type 1–specific Brg1 recruitment and remodeling of nucleosomes positioned at the IFN- promoter are Stat4 dependent. J. Exp. Med. 203, 1493–1505 (2006).
34. L. Wei, G. Vahedi, H.-W. Sun, W. T. Watford, H. Takatori, H. L. Ramos, H. Takahashi, J. Liang, G. Gutierrez-Cruz, C. Zang, W. Peng, J. J. O’Shea, Y. Kanno, Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation. Immunity 32, 840–851 (2010).
35. D. Levanon, D. Bettoun, C. Harris-Cerruti, E. Woolf, V. Negreanu, R. Eilam, Y. Bernstein, D. Goldenberg, C. Xiao, M. Fliegauf, E. Kremer, F. Otto, O. Brenner, A. Lev-Tov, Y. Groner, The Runx3 transcription factor regulates development and survival of TrkC dorsal root ganglia neurons. EMBO J. 21, 3454–3463 (2002).
36. D. Levanon, V. Negreanu, J. Lotem, K. R. Bone, O. Brenner, D. Leshkowitz, Y. Groner, Transcription factor Runx3 regulates interleukin-15-dependent natural killer cell activation. Mol. Cell. Biol. 34, 1158–1169 (2014).
37. S.-I. Ohno, T. Sato, K. Kohu, K. Takeda, K. Okumura, M. Satake, S. Habu, Runx proteins are involved in regulation of CD122, Ly49 family and IFN- expression during NK cell differentiation. Int. Immunol. 20, 71–79 (2008).
38. S. K. Anderson, Transcriptional regulation of NK cell receptors. Curr. Top. Microbiol. Immunol. 298, 59–75 (2006).
39. C. B. Lai, D. L. Mager, Role of runt-related transcription factor 3 (RUNX3) in transcription regulation of natural cytotoxicity receptor 1 (NCR1/NKp46), an activating natural killer (NK) cell receptor. J. Biol. Chem. 287, 7324–7334 (2012).
40. J. Lotem, D. Levanon, V. Negreanu, D. Leshkowitz, G. Friedlander, Y. Groner, Runx3-mediated transcriptional program in cytotoxic lymphocytes. PLOS ONE 8, e80467 (2013).
41. N. A. Bezman, C. C. Kim, J. C. Sun, G. Min-Oo, D. W. Hendricks, Y. Kamimura, J. A. Best, A. W. Goldrath, L. L. Lanier, The Immunological Genome Project Consortium, Molecular definition of the identity and activation of natural killer cells. Nat. Immunol. 13, 1000–1009 (2012).
42. Q. Wang, T. Stacy, J. D. Miller, A. F. Lewis, T.-L. Gu, X. Huang, J. H. Bushweller, J.-C. Bories, F. W. Alt, G. Ryan, P. P. Liu, A. Wynshaw-Boris, M. Binder, M. Marín-Padilla, A. H. Sharpe, N. A. Speck, The CBF subunit is essential for CBF2 (AML1) function in vivo. Cell 87, 697–708 (1996).
43. R. Setoguchi, M. Tachibana, Y. Naoe, S. Muroi, K. Akiyama, C. Tezuka, T. Okuda, I. Taniuchi, Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 319, 822–825 (2008).
44. M. A. Firth, S. Madera, A. M. Beaulieu, G. Gasteiger, E. F. Castillo, K. S. Schluns, M. Kubo, P. B. Rothman, E. Vivier, J. C. Sun, Nfil3-independent lineage maintenance and antiviral response of natural killer cells. J. Exp. Med. 210, 2981–2990 (2013).
45. T. L. Geiger, M. C. Abt, G. Gasteiger, M. A. Firth, M. H. O’Connor, C. D. Geary, T. E. O’Sullivan, M. R. van den Brink, E. G. Pamer, A. M. Hanash, J. C. Sun, Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens. J. Exp. Med. 211, 1723–1731 (2014).
46. C. Seillet, L. C. Rankin, J. R. Groom, L. A. Mielke, J. Tellier, M. Chopin, N. D. Huntington, G. T. Belz, S. Carotta, Nfil3 is required for the development of all innate lymphoid cell subsets. J. Exp. Med. 211, 1733–1740 (2014).
47. W. Xu, R. G. Domingues, D. Fonseca-Pereira, M. Ferreira, H. Ribeiro, S. Lopez-Lastra, Y. Motomura, L. Moreira-Santos, F. Bihl, V. Braud, B. Kee, H. Brady, M. C. Coles, C. Vosshenrich, M. Kubo, J. P. Di Santo, H. Veiga-Fernandes, NFIL3 orchestrates the emergence of common helper innate lymphoid cell precursors. Cell Rep. 10, 2043–2054 (2015).
48. X. Yu, Y. Wang, M. Deng, Y. Li, K. A. Ruhn, C. C. Zhang, L. V. Hooper, The basic leucine zipper transcription factor NFIL3 directs the development of a common innate lymphoid cell precursor. Elife 3, e04406 (2014).
49. E. Narni-Mancinelli, J. Chaix, A. Fenis, Y. M. Kerdiles, N. Yessaad, A. Reynders, C. Gregoire, H. Luche, S. Ugolini, E. Tomasello, T. Walzer, E. Vivier, Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc. Natl. Acad. Sci. U.S.A. 108, 18324–18329 (2011).
50. J. D. Growney, H. Shigematsu, Z. Li, B. H. Lee, J. Adelsperger, R. Rowan, D. P. Curley, J. L. Kutok, K. Akashi, I. R. Williams, N. A. Speck, D. G. Gilliland, Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 106, 494–504 (2005).
51. Y. Naoe, R. Setoguchi, K. Akiyama, S. Muroi, M. Kuroda, F. Hatam, D. R. Littman, I. Taniuchi, Repression of interleukin-4 in T helper type 1 cells by Runx/Cbf binding to the Il4 silencer. J. Exp. Med. 204, 1749–1755 (2007).
52. M. H. Kaplan, Y.-L. Sun, T. Hoey, M. J. Grusby, Impaired IL-12 responses and enhanced development of TH2 cells in Stat4-deficient mice. Nature 382, 174–177 (1996).
53. N. Fodil-Cornu, S.-H. Lee, S. Belanger, A. P. Makrigiannis, C. A. Biron, R. M. Buller, S. M. Vidal, Ly49h-deficient C57BL/6 mice: A new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. J. Immunol. 181, 6394–6405 (2008).
54. J. C. Sun, J. N. Beilke, L. L. Lanier, Adaptive immune features of natural killer cells. Nature 457, 557–561 (2009).
55. L. R. Johnson, O.-E. Weizman, M. Rapp, S. S. Way, J. C. Sun, Epitope-specific vaccination limits clonal expansion of heterologous naive T cells during viral challenge. Cell Rep. 17, 636–644 (2016).
56. A. M. Bolger, M. Lohse, B. Usadel, Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).
57. B. Langmead, S. L. Salzberg, Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
58. Y. Zhang, T. Liu, C. A. Meyer, J. Eeckhoute, D. S. Johnson, B. E. Bernstein, C. Nusbaum, R. M. Myers, M. Brown, W. Li, X. S. Liu, Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
59. Q. Li, J. B. Brown, H. Huang, P. J. Bickel, Measuring reproducibility of high-throughput experiments. Ann. Appl. Stat. 5, 1752–1779 (2011).
60. L. J. Zhu, C. Gazin, N. D. Lawson, H. Pagès, S. M. Lin, D. S. Lapointe, M. R. Green, ChIPpeakAnno: A bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics 11, 237 (2010).
61. M. I. Love, W. Huber, S. Anders, Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
62. H.-M. Zhang,H. Chen,W. Liu,H. Liu,J. Gong,H. Wang,A.-Y. Guo,AnimalTFDB:Acomprehensive animal transcription factor database. Nucleic Acids Res. 40, D144–D149 (2012).
63. F. Hahne, R. Ivanek, Visualizing genomic data using Gviz and bioconductor. Methods Mol. Biol. 1418, 335–351 (2016).
64. W. Luo, M. S. Friedman, K. Shedden, K. D. Hankenson, P. J. Woolf, GAGE: Generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics 10, 161 (2009).
65. G. Yu, Q.-Y. He, ReactomePA: An R/Bioconductor package for reactome pathway analysis and visualization. Mol. Biosyst. 12, 477–479 (2016).